Results 141 to 150 of about 7,402 (202)

Immediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study. [PDF]

BMC Med
Zhang F, Cai W, Wu H, Ma P, Zhao Q, Wei H, Lu H, Wang H, He S, Chen Z, Chen Y, Wang M, Yun X, Zhou Z, Fu H, Qin H.   +15 more
europepmc   +1 more source

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg. [PDF]

J Int AIDS Soc
Natukunda E, Gaur AH, Kosalaraksa P, Hellström E, Strehlau R, Liberty A, Cox S, Leisegang R, Palaparthy R, Crowe S, Vieira V, Kersey K, Rakhmanina N.   +12 more
europepmc   +1 more source

Orthostatic hypotension in a patient with HIV: uncovering adrenal insufficiency from fluticasone-cobicistat interactions. [PDF]

CMAJ
Dienes S, Nunn R, Lai A.
europepmc   +1 more source

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]

Clin Infect Dis
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR.   +8 more
europepmc   +1 more source

Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]

Open Forum Infect Dis
Cutshaw MK, Harding M, Davenport CA, Okeke NL.   +3 more
europepmc   +1 more source

Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility survey. [PDF]

HIV Med
Ballif M, Correia da Silva Saúde M, Haerry D, Stoeckle M, Schmid P, Braun D, Calmy A, Wandeler G, Surial B.   +8 more
europepmc   +1 more source

Post-Treatment HIV Control in a Married Couple. [PDF]

Infect Dis Clin Microbiol
Kaya A, Özdemir G, Yörük G, Durmaz Konyalı G, Kaya SY.   +4 more
europepmc   +1 more source

All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. [PDF]

Clin Infect Dis
Giacomelli A, Capra N, Lolatto R, Gagliardini R, Clemente T, Calza L, Torti C, Lagi F, Fornabaio C, Marchetti G, Orofino G, Spagnuolo V, for PRESTIGIO Study Group .   +12 more
europepmc   +1 more source

Comparison of treatment-emergent resistance-associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta-analysis. [PDF]

HIV Med
Rashid I, Unger NR, Willis C, Dhippayom T, Ramgopal M, Sherman EM, Yared N, Safran R, Swiatlo E, Weinberg AR, Navadeh S, Schmutz HW, Chaiyakunapruk N.   +12 more
europepmc   +1 more source

Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. [PDF]

Drug Des Devel Ther
Lin HY, Hu SC, Pai TY, Lin FJ, Wu CC.
europepmc   +1 more source